PL1648484T3 - Formulacje do leczenia stanów chorobowych związanych z zapaleniem stawów - Google Patents

Formulacje do leczenia stanów chorobowych związanych z zapaleniem stawów

Info

Publication number
PL1648484T3
PL1648484T3 PL04735566T PL04735566T PL1648484T3 PL 1648484 T3 PL1648484 T3 PL 1648484T3 PL 04735566 T PL04735566 T PL 04735566T PL 04735566 T PL04735566 T PL 04735566T PL 1648484 T3 PL1648484 T3 PL 1648484T3
Authority
PL
Poland
Prior art keywords
formulations
treatment
arhritis conditions
conditions
arhritis
Prior art date
Application number
PL04735566T
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PL1648484T3 publication Critical patent/PL1648484T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL04735566T 2003-06-27 2004-06-01 Formulacje do leczenia stanów chorobowych związanych z zapaleniem stawów PL1648484T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001311A ITMI20031311A1 (it) 2003-06-27 2003-06-27 Formulazioni per il trattamento di disturbi artrosici.
PCT/EP2004/005875 WO2005002611A1 (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions
EP04735566A EP1648484B1 (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions

Publications (1)

Publication Number Publication Date
PL1648484T3 true PL1648484T3 (pl) 2009-04-30

Family

ID=30131307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04735566T PL1648484T3 (pl) 2003-06-27 2004-06-01 Formulacje do leczenia stanów chorobowych związanych z zapaleniem stawów

Country Status (21)

Country Link
US (1) US8343554B2 (pl)
EP (1) EP1648484B1 (pl)
JP (1) JP2007513051A (pl)
KR (2) KR101119418B1 (pl)
CN (1) CN1812802A (pl)
AT (1) ATE414526T1 (pl)
AU (1) AU2004253242B2 (pl)
BR (1) BRPI0411895B1 (pl)
CA (1) CA2530494C (pl)
DE (1) DE602004017871D1 (pl)
DK (1) DK1648484T3 (pl)
ES (1) ES2315662T3 (pl)
IL (1) IL172773A (pl)
IT (1) ITMI20031311A1 (pl)
NO (1) NO333877B1 (pl)
NZ (1) NZ544400A (pl)
PL (1) PL1648484T3 (pl)
PT (1) PT1648484E (pl)
RU (1) RU2349336C2 (pl)
SI (1) SI1648484T1 (pl)
WO (1) WO2005002611A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040439A1 (it) * 2004-09-16 2004-12-16 Ca Di Group S R L Prodotto con azione antinfiammatoria selettiva e azione contro la fibrogenesi tissutale.
ITMI20051349A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratto di salice uso e formulazioni che lo contengono
CN100417415C (zh) * 2006-06-28 2008-09-10 文彦春 浸润治疗关节炎的药物
EP1886712A1 (en) * 2006-08-08 2008-02-13 Indena S.P.A. Compositions for the treatment of chronic degenerative inflammatory conditions
FR2907339B1 (fr) * 2006-10-20 2009-04-24 Inneov Lab Composition comprenant de la glucosamine et au moins un polyphenol.
CN101371823B (zh) * 2007-03-19 2010-09-15 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释胶囊的制备工艺
FR2918376B1 (fr) 2007-07-04 2011-10-28 Mathieu Borge Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
WO2009031826A1 (en) * 2007-09-04 2009-03-12 Catholic University Industry Academic Cooperation Foundation Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same
WO2010029578A2 (en) 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
KR101096574B1 (ko) * 2008-12-12 2011-12-20 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물
KR101099021B1 (ko) * 2009-04-24 2011-12-28 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골관절염 예방 또는 치료용 약학 조성물
JP5734578B2 (ja) * 2009-09-03 2015-06-17 ナガセケムテックス株式会社 ヒアルロン酸増量剤
US8464407B2 (en) * 2009-12-23 2013-06-18 Bae Systems Aerospace & Defense Group Inc. Quick release buckle with dual release
WO2011099029A1 (en) 2010-02-15 2011-08-18 Laila Nutraceuticals A novel boswellia low polar gum resin extract and its synergistic compositions
PH12012501787A1 (en) 2010-03-15 2012-12-10 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
EP2723357A4 (en) 2011-06-21 2015-04-01 Bvw Holding Ag MEDICAL DEVICE COMPRISING BOSWELLIC ACID
RU2476213C1 (ru) * 2012-02-15 2013-02-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения и социального развития" (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздравсоцразвития России) Способ комплексного лечения вторичного остеоартроза при ревматоидном артрите
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤
JP6153436B2 (ja) * 2013-09-27 2017-06-28 小林製薬株式会社 経口組成物
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
CN111110863A (zh) * 2020-01-21 2020-05-08 郑州大学 大黄酸磷脂复合物及其制备方法和应用、大黄酸磷脂复合物长循环脂质体及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3970M (pl) 1963-11-26 1966-02-28
GB1155973A (en) * 1965-06-26 1969-06-25 Ajinomoto Kk Spiroacetal Diamine Derivatives and their use as Curing Agents for Epoxy Resins
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
DE3602670A1 (de) 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
US5629351A (en) 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
DE19531067A1 (de) 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
JP4153057B2 (ja) 1997-03-10 2008-09-17 中国化薬株式会社 Ｄ−グルクロノラクトンの製造方法
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
AU5010800A (en) * 1999-05-14 2000-12-05 Regents Of The University Of California, The Anti-inflammatory therapy for inflammatory mediated infection
JP2002153294A (ja) * 2000-11-21 2002-05-28 Hayashibara Biochem Lab Inc グルクロン酸類及び／又はｄ−グルクロノラクトンの製造方法とその用途
US6451045B1 (en) * 2001-02-22 2002-09-17 Alsius Corporation Heat exchange catheter having a helically wrapped heat exchanger
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation

Also Published As

Publication number Publication date
BRPI0411895B1 (pt) 2015-11-10
IL172773A (en) 2010-12-30
US8343554B2 (en) 2013-01-01
IL172773A0 (en) 2006-04-10
WO2005002611A1 (en) 2005-01-13
RU2349336C2 (ru) 2009-03-20
ITMI20031311A1 (it) 2004-12-28
ES2315662T3 (es) 2009-04-01
KR20060032147A (ko) 2006-04-14
JP2007513051A (ja) 2007-05-24
BRPI0411895A (pt) 2006-08-29
KR101119418B1 (ko) 2012-02-22
PT1648484E (pt) 2009-01-09
SI1648484T1 (sl) 2009-02-28
CA2530494A1 (en) 2005-01-13
RU2005140573A (ru) 2006-06-10
AU2004253242B2 (en) 2010-02-18
NZ544400A (en) 2009-04-30
NO20056161L (no) 2005-12-23
EP1648484A1 (en) 2006-04-26
ATE414526T1 (de) 2008-12-15
AU2004253242A1 (en) 2005-01-13
CA2530494C (en) 2013-04-30
DK1648484T3 (da) 2009-01-19
NO333877B1 (no) 2013-10-07
US20060280811A1 (en) 2006-12-14
KR20110039400A (ko) 2011-04-15
ITMI20031311A0 (it) 2003-06-27
DE602004017871D1 (de) 2009-01-02
CN1812802A (zh) 2006-08-02
EP1648484B1 (en) 2008-11-19

Similar Documents

Publication Publication Date Title
IL172773A (en) Formulations for the treatment of arthritis conditions
MXPA04001876A (es) Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
PL371853A1 (pl) Miejscowe kompozycje farmaceutyczne zawierające proantocyjanidyny do leczenia zapalenia skóry
TW200510416A (en) P38 inhibitors and methods of use thereof
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
GB0129260D0 (en) Pharmaceutical compositions and their uses
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2004041269A3 (en) New use for pharmaceutical composition
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2004045557A3 (en) Novel lapachone compounds and methods of use thereof
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
WO2005011611A3 (en) Bicyclic compounds and compositions as pdf inhibitors
MY140194A (en) Novel fusidic acid derivatives
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
PL355113A1 (pl) Nowe pochodne kwasu fusydowego
WO2006078833A3 (en) Novel coumarin derivatives as ion channel openers
BRPI0414423A (pt) inibidores de pace4, suas composições farmacêuticas e respectivos usos